PATENT CLAIM ANALYSIS

Application Number: 16138837
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-05
Patent Classification: ["514", "438000"]

Abstract:
Disclosed are beta and gamma-amino isoquinoline amide compounds and substituted benzamide compounds. In particular, the invention provides compounds that affect the function of kinases in a cell and that are useful as therapeutic agents or with therapeutic agents. The compounds of the invention are useful in the treatment of a variety of diseases and conditions including eye diseases such as glaucoma, cardiovascular diseases, and diseases characterized by abnormal growth, such as cancers. The invention further provides compositions containing the beta or gamma-amino isoquinoline amide compounds or substituted benzamide compounds.

Claim (Index 41):
The method of  claim 38 , wherein the cell is in a subject.

Metadata:
- Claim Count in Document: 74.0
- Percentile: 97.0
- Lexical Diversity: 1.97959
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14273895', '12180259', '14790376', '13442263', '14583439']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8129934560745806
- 35 USC 102 Novelty (BERT): 0.5412689597806326
- Combined Prediction Score: 0.7858210064451859
- Mean Citation Score: 364.977104
- Max Citation Score: 379.91092
- Similarity Product: 203.2348479995108

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test